我院2010—2015年医院制剂的药物利用分析
|
摘要
目的:分析医院制剂的应用情况,为临床合理用药和医院制剂的定位及发展提供参考。方法:统计2010—2015年医院制剂的使用量、用药金额、用药频度等指标,分析医院院内制剂使用的特点及其发展趋势。结果:2010—2015年,医院的院内制剂以中药制剂为主,片剂、合剂、胶囊剂为主导剂型。专科用药方面,骨伤科、消化系统、呼吸系统、风湿病、耳鼻喉科、妇科用药年用量均在10万瓶以上,其中骨伤科、消化系统用药金额排名前2名,专科制剂昆藤通痹合剂和通痹宁片(风湿病用药),复方川贝枇杷止咳露(呼吸系统用药),胃肠舒片、加味胃炎消片和肠炎安片(消化系统用药),袁氏生脉成骨片(骨伤科用药)始终保持DDDs排名前10位。结论:开展多中心临床研究,"盘活"了医院专科制剂的应用,积极开发特色中药制剂,既为临床合理用药提供数据支持;也推动医院制剂的发展的方向。
Objective: To investigate the utilization of hospital preparations in our hospital, and to provide the reference for rational use, location and development of them. Methods: The amount, consumption sum and DDDs of hospital preparations in our hospital from 2010 to 2015 were statistically analyzed to explore the characteristic and orientation. Results: The leading preparations were Chinese medicine hospital preparations, which were mainly consist of tablets, mixture, capsules. The annual amount of orthopedic drugs, digestive system drugs,respiratory system drugs, rheumatic drugs, ENT drugs, gynecological drugs were more than 100,000 bottles. The consumption sum of orthopedic drugs and digestive system drugs rank top two. Top 10 preparations in the list of DDDs in our hospital were Kunteng Tongbi Heji(昆藤通痹合剂) and Tongbi'ning Pian(通痹宁片)(rheumatic drugs), Fufang Chuanbei Pipa Zhikelu(复方川贝枇杷止咳露)(respiratory system drugs), Weichangshu Pian(胃肠舒片), Jiawei Weiyanxiao Pian(加味胃炎消片) and Changyan'an Pian(肠炎安片) which were digestive system drugs, Yuanshi Shengmai Chenggu Pian( 袁氏生脉成骨片)(orthopedic treatment drugs). Conclusions:With promoting the application of hospital preparations by conducting multi-center clinical study and actively developing TCM preparations with characteristics, the medication needs could be met. It's the supportion of the clinical use of drugs, and the direction of the hospital preparations for survival and development.
Objective: To investigate the utilization of hospital preparations in our hospital, and to provide the reference for rational use, location and development of them. Methods: The amount, consumption sum and DDDs of hospital preparations in our hospital from 2010 to 2015 were statistically analyzed to explore the characteristic and orientation. Results: The leading preparations were Chinese medicine hospital preparations, which were mainly consist of tablets, mixture, capsules. The annual amount of orthopedic drugs, digestive system drugs,respiratory system drugs, rheumatic drugs, ENT drugs, gynecological drugs were more than 100,000 bottles. The consumption sum of orthopedic drugs and digestive system drugs rank top two. Top 10 preparations in the list of DDDs in our hospital were Kunteng Tongbi Heji(昆藤通痹合剂) and Tongbi'ning Pian(通痹宁片)(rheumatic drugs), Fufang Chuanbei Pipa Zhikelu(复方川贝枇杷止咳露)(respiratory system drugs), Weichangshu Pian(胃肠舒片), Jiawei Weiyanxiao Pian(加味胃炎消片) and Changyan'an Pian(肠炎安片) which were digestive system drugs, Yuanshi Shengmai Chenggu Pian( 袁氏生脉成骨片)(orthopedic treatment drugs). Conclusions:With promoting the application of hospital preparations by conducting multi-center clinical study and actively developing TCM preparations with characteristics, the medication needs could be met. It's the supportion of the clinical use of drugs, and the direction of the hospital preparations for survival and development.
引文
[1]王文明,严振,张雷红,等.广东省医院制剂发展现状的调查分析[J].中国药房,2013,24(32):2986.
[2]梅全喜,范文昌.医院中药制剂开发的意义研发方向及应注意的几个问题[J].中医药管理杂志,2011,4(19):357.
[3]张玉梅,张梅玲,刘正跃,等.第二军医大学长海医院2004-2013年新剂型药物用药金额及用药频度分析[J].药学服务与研究,2014,14(4):286.
[4]李艳,丁庆明.限定日剂量在药物利用研究中的应用[J].中国执业药师,2010,7(9):6.
[5]颜婷,陈鸣,闫俊峰.我院2010-2012年医院制剂药物利用研究[J].中国药房,2014,25(14):1271.
[6]宋洪涛,张晶,周欣,等.当前医院制剂发展策略与研发思路探讨[J].中国药房,2009,20(13):997.
[2]梅全喜,范文昌.医院中药制剂开发的意义研发方向及应注意的几个问题[J].中医药管理杂志,2011,4(19):357.
[3]张玉梅,张梅玲,刘正跃,等.第二军医大学长海医院2004-2013年新剂型药物用药金额及用药频度分析[J].药学服务与研究,2014,14(4):286.
[4]李艳,丁庆明.限定日剂量在药物利用研究中的应用[J].中国执业药师,2010,7(9):6.
[5]颜婷,陈鸣,闫俊峰.我院2010-2012年医院制剂药物利用研究[J].中国药房,2014,25(14):1271.
[6]宋洪涛,张晶,周欣,等.当前医院制剂发展策略与研发思路探讨[J].中国药房,2009,20(13):997.